Literature DB >> 30620696

Selective Chemoembolization of Caudate Lobe Hepatocellular Carcinoma: Anatomy and Procedural Techniques.

Hyo-Cheol Kim1, Shiro Miyayama1, Jin Wook Chung1.   

Abstract

Transarterial chemoembolization is the most common treatment for unresectable hepatocellular carcinomas (HCCs). However, when an HCC is located in the caudate lobe, many interventional radiologists are reluctant to perform chemoembolization and percutaneous ablation owing to the tumor's complex vascular supply and deep location. With the advent of C-arm CT, rendering the three-dimensional display of the hepatic artery and detecting the tumor-feeding vessels are possible and can help guide interventional radiologists to the tumor. The common origins of the caudate artery include the right hepatic artery, left hepatic artery, right anterior hepatic artery, and right posterior hepatic artery. The origins of the tumor-feeding arteries of a caudate lobe HCC can vary depending on the tumor's subsegmental location. Caudate lobe HCCs are commonly fed by multiple caudate arteries that are connected. In addition, extrahepatic collateral arteries frequently supply recurrent tumors in the caudate lobe. The caudate artery can supply portal vein thrombi or biliary tumor thrombi in patients with HCC. Several techniques such as preshaping the microcatheter or using the shepherd's hook technique are needed to catheterize the caudate artery in complex cases. Although uncommon, bile duct stricture is a serious complication following selective chemoembolization through the caudate artery. Identification and catheterization of the caudate artery have become possible in most patients by using C-arm CT and a fine microcatheter system, respectively. The authors review the anatomy of the caudate artery with C-arm CT and describe basic technical considerations in selective chemoembolization for caudate lobe HCCs. Unusual circumstances that require catheterization and techniques used for catheterizing the caudate artery are also described. Online supplemental material is available for this article. ©RSNA, 2019.

Entities:  

Mesh:

Year:  2019        PMID: 30620696     DOI: 10.1148/rg.2019180110

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  4 in total

1.  Caudate Lobe Hepatocellular Carcinoma Treated with Sequential Transarterial Chemoembolization and Iodine 125 Seeds Implantation: A Single-Center Retrospective Study.

Authors:  Liangliang Yan; Lei Chen; Kun Qian; Xuefeng Kan; Hongsen Zhang; Bin Liang; Chuansheng Zheng
Journal:  Cancer Manag Res       Date:  2021-05-13       Impact factor: 3.989

2.  Superselective Transarterial Chemoembolization for Unresectable or "Ablation Unsuitable" Hepatocellular Carcinoma in the Caudate Lobe: A Real World, Single-Center Retrospective Study.

Authors:  Liangliang Yan; Yanqiao Ren; Kun Qian; Xuefeng Kan; Hongsen Zhang; Lei Chen; Bin Liang; Chuansheng Zheng
Journal:  Front Oncol       Date:  2021-10-28       Impact factor: 6.244

3.  Advances in the interventional therapy of hepatocellular carcinoma originating from the caudate lobe.

Authors:  Shanmiao Ke
Journal:  J Interv Med       Date:  2022-05-21

4.  Effectiveness of Transarterial Chemoembolization-First Treatment for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.

Authors:  Sung Won Chung; Min Kyung Park; Young Youn Cho; Youngsu Park; Cheol-Hyung Lee; Hyunwoo Oh; Heejoon Jang; Minseok Albert Kim; Sun Woong Kim; Joon Yeul Nam; Yun Bin Lee; Eun Ju Cho; Su Jong Yu; Hyo-Cheol Kim; Yoon Jun Kim; Jin Wook Chung; Jung-Hwan Yoon; Jeong-Hoon Lee
Journal:  J Hepatocell Carcinoma       Date:  2021-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.